MedPath

Azacitidine

These highlights do not include all the information needed to use AZACITIDINE FOR INJECTION safely and effectively. See full prescribing information for AZACITIDINE FOR INJECTION. AZACITIDINE for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2004

Approved
Approval ID

70140e11-33f1-2240-e053-2991aa0a0480

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 4, 2024

Manufacturers
FDA

Accord Healthcare Inc.

DUNS: 604222237

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Azacitidine

PRODUCT DETAILS

NDC Product Code16729-306
Application NumberANDA207475
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS, SUBCUTANEOUS
Effective DateJanuary 4, 2024
Generic NameAzacitidine

INGREDIENTS (2)

MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
AZACITIDINEActive
Quantity: 100 mg in 1 1
Code: M801H13NRU
Classification: ACTIB
© Copyright 2025. All Rights Reserved by MedPath
Azacitidine - FDA Approval | MedPath